These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 33811098)
1. Impact of corticosteroids in hospitalised COVID-19 patients. Ho KS; Narasimhan B; Difabrizio L; Rogers L; Bose S; Li L; Chen R; Sheehan J; El-Halabi MA; Sarosky K; Wang Z; Eisenberg E; Powell C; Steiger D BMJ Open Respir Res; 2021 Apr; 8(1):. PubMed ID: 33811098 [TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
3. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739 [TBL] [Abstract][Full Text] [Related]
4. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit. Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192 [TBL] [Abstract][Full Text] [Related]
5. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765 [TBL] [Abstract][Full Text] [Related]
6. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients. Bahl A; Johnson S; Chen NW Intern Emerg Med; 2021 Sep; 16(6):1593-1603. PubMed ID: 33547620 [TBL] [Abstract][Full Text] [Related]
7. Effect of Corticosteroids on Mortality in Hospitalized COVID-19 Patients Not Receiving Invasive Mechanical Ventilation. Fusina F; Albani F; Granato E; Meloni A; Rozzini R; Sabatini T; Stellini R; Terragnoli P; Rosano A; Abu Hilal M; Natalini G Clin Pharmacol Ther; 2021 Jun; 109(6):1660-1667. PubMed ID: 33792037 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study. Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F; Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial. Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638 [TBL] [Abstract][Full Text] [Related]
10. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662 [TBL] [Abstract][Full Text] [Related]
11. Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients. Albani F; Fusina F; Granato E; Capotosto C; Ceracchi C; Gargaruti R; Santangelo G; Schiavone L; Taranto MS; Tosati C; Vavassori E; Natalini G Sci Rep; 2021 Jan; 11(1):1015. PubMed ID: 33441909 [TBL] [Abstract][Full Text] [Related]
12. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study. Monedero P; Gea A; Castro P; Candela-Toha AM; Hernández-Sanz ML; Arruti E; Villar J; Ferrando C; Crit Care; 2021 Jan; 25(1):2. PubMed ID: 33397463 [TBL] [Abstract][Full Text] [Related]
13. Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and intensive care unit admission in patients with COVID-19 according to patients' oxygen requirements. Tortajada C; Colomer E; Andreu-Ballester JC; Esparcia A; Oltra C; Flores J J Med Virol; 2021 Mar; 93(3):1817-1823. PubMed ID: 33107607 [TBL] [Abstract][Full Text] [Related]
14. Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19. Lafaurie M; Martin-Blondel G; Delobel P; Kamar N; Charpentier S; Sommet A; Moulis G; BMC Pharmacol Toxicol; 2021 Mar; 22(1):14. PubMed ID: 33706794 [TBL] [Abstract][Full Text] [Related]
15. Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study. Chen Q; Song Y; Wang L; Zhang Y; Han L; Liu J; Yang M; Ma J; Wang T Expert Rev Respir Med; 2021 Apr; 15(4):543-552. PubMed ID: 33249945 [TBL] [Abstract][Full Text] [Related]
16. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19. Liu Z; Li X; Fan G; Zhou F; Wang Y; Huang L; Yu J; Yang L; Shang L; Xie K; Xu J; Huang Z; Gu X; Li H; Zhang Y; Wang Y; Huang Z; Cao B Clin Microbiol Infect; 2021 Jan; 27(1):112-117. PubMed ID: 33007478 [TBL] [Abstract][Full Text] [Related]
17. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial. Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A; Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496 [TBL] [Abstract][Full Text] [Related]
18. Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study. Li Y; Meng Q; Rao X; Wang B; Zhang X; Dong F; Yu T; Li Z; Feng H; Zhang J; Chen X; Li H; Cheng Y; Hong X; Wang X; Yin Y; Zhang Z; Wang D Crit Care; 2020 Dec; 24(1):698. PubMed ID: 33339536 [TBL] [Abstract][Full Text] [Related]
19. Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study. Russo G; Solimini A; Zuccalà P; Zingaropoli MA; Carraro A; Pasculli P; Perri V; Marocco R; Kertusha B; Del Borgo C; Del Giudice E; Fondaco L; Tieghi T; D'Agostino C; Oliva A; Vullo V; Ciardi MR; Mastroianni CM; Lichtner M PLoS One; 2021; 16(9):e0257376. PubMed ID: 34506608 [TBL] [Abstract][Full Text] [Related]